{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:57:33Z","timestamp":1793908653514,"version":"4.8.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Department of Science and Technology of Hunan Province","doi-asserted-by":"publisher","award":["2024JK2119"],"award-info":[{"award-number":["2024JK2119"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002767","name":"Department of Science and Technology of Hunan Province","doi-asserted-by":"publisher","award":["2020SK1013"],"award-info":[{"award-number":["2020SK1013"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470333"],"award-info":[{"award-number":["82470333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770337"],"award-info":[{"award-number":["81770337"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ30033"],"award-info":[{"award-number":["2021JJ30033"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30791"],"award-info":[{"award-number":["2023JJ30791"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ6593"],"award-info":[{"award-number":["2024JJ6593"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.diabres.2026.113092","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:17:40Z","timestamp":1767831460000},"page":"113092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The burden and mortality impact of cardiovascular disease\u2013metabolic dysfunction\u2013associated steatotic liver disease comorbidity"],"prefix":"10.1016","volume":"232","author":[{"given":"Siyuan","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuzhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113092_b0005","unstructured":"Global Burden of Cardiovascular Diseases and Risk Factors Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. J Am Coll Cardiol. 2025;22:2167-243."},{"key":"10.1016\/j.diabres.2026.113092_b0010","doi-asserted-by":"crossref","unstructured":"GBD 2023 Causes of Death Collaborators. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406:1811-72.","DOI":"10.1016\/S0140-6736(25)01917-8"},{"key":"10.1016\/j.diabres.2026.113092_b0015","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.diabres.2026.113092_b0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.diabres.2026.113092_b0025","first-page":"1","article-title":"The global cardiovascular\u2013liver\u2013metabolic syndemic: epidemiology, trends and challenges","author":"Chew","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.diabres.2026.113092_b0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","article-title":"Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi approach","volume":"151","author":"Chew","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2026.113092_b0035","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCRESAHA.125.325492","article-title":"Decoding the liver-heart axis in cardiometabolic diseases","volume":"136","author":"Capone","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2026.113092_b0040","article-title":"The cardiohepatic axis in metabolic disease: liver to heart","volume":"10","author":"Hakeem","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.diabres.2026.113092_b0045","first-page":"487","article-title":"Metabolic dysfunction-associated steatotic liver disease and the heart","volume":"82","author":"Driessen","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.diabres.2026.113092_b0050","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s11739-025-03895-6","article-title":"Global burden and risk factors of MASLD: trends from 1990 to 2021 and predictions to 2030","volume":"20","author":"Huang","year":"2025","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.diabres.2026.113092_b0055","first-page":"10","article-title":"Global burden of MASLD-IBD comorbidity from 1990 to 2021 and trend prediction to 2050","author":"Xu","year":"2025","journal-title":"Int J Surg"},{"key":"10.1016\/j.diabres.2026.113092_b0060","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1093\/eurheartj\/ehae466","article-title":"European society of cardiology: the 2023 atlas of cardiovascular disease statistics","volume":"45","author":"Timmis","year":"2024","journal-title":"Eur Heart J"},{"issue":"32","key":"10.1016\/j.diabres.2026.113092_b0065","first-page":"539","article-title":"to 2021: an analysis for the Global Burden of Disease Study 2021","volume":"2024","author":"Wang","year":"1990","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.diabres.2026.113092_b0070","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2026.113092_b0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eprac.2022.10.007","article-title":"A meta-analysis on associated risk of mortality in nonalcoholic fatty liver disease","volume":"29","author":"Fu","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/j.diabres.2026.113092_b0080","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1111\/dom.16568","article-title":"Metabolic dysfunction-associated steatotic liver disease and sex-specific risk of fatal and non-fatal cardiovascular events: a meta-analysis","volume":"27","author":"Jamalinia","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113092_b0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12933-022-01725-z","article-title":"The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study","volume":"21","author":"Park","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2026.113092_b0090","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic fatty liver disease and fibrosis associatedwith increased risk of cardiovascular eventsinaprospective study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2026.113092_b0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.diabres.2026.113092_b0100","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review","author":"Tilg","year":"2025","journal-title":"Jama."},{"key":"10.1016\/j.diabres.2026.113092_b0105","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/eurheartj\/ehaf314","article-title":"Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement","volume":"46","author":"Romeo","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2026.113092_b0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","article-title":"Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Chen","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2026.113092_b0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endo"},{"key":"10.1016\/j.diabres.2026.113092_b0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2024.08.011","article-title":"Association of food insecurity with MASLD prevalence and liver-related mortality","volume":"82","author":"Younossi","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2026.113092_b0125","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.14309\/ajg.0000000000003421","article-title":"Social determinants of health associated with metabolic dysfunction-associated steatotic liver disease prevalence and severity: a systematic review and meta-analysis","volume":"120","author":"Abu-Rumaileh","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diabres.2026.113092_b0130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2026.113092_b0135","first-page":"41","article-title":"Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease","volume":"4","author":"Amedeo","year":"2024","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.diabres.2026.113092_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155607","article-title":"Hepatic insulin receptor: new views on the mechanisms of liver disease","volume":"145","author":"Lee","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2026.113092_b0145","article-title":"Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort study","volume":"48","author":"Boeckmans","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.diabres.2026.113092_b0150","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1186\/s12889-025-23883-x","article-title":"Prognostic value of FIB-4 and NFS for cardiovascular events in patients with and without NAFLD","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.diabres.2026.113092_b0155","first-page":"903","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol"},{"key":"10.1016\/j.diabres.2026.113092_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106626","article-title":"Cardiovascular risk and functional burden at midlife: prospective associations of isotemporal reallocations of accelerometer-measured physical activity and sedentary time in the CARDIA study","volume":"150","author":"Full","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.diabres.2026.113092_b0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12933-025-02869-4","article-title":"Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident cardiovascular disease in middle-aged and older Chinese adults: a nationwide cohort study","volume":"24","author":"Ma","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2026.113092_b0170","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1572-0241.2008.02034.x","article-title":"Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study","volume":"103","author":"Dunn","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diabres.2026.113092_b0175","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the prevalence of metabolic syndrome in the United States, 2011-2016","volume":"323","author":"Hirode","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2026.113092_b0180","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/postmj\/qgad008","article-title":"Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011\u201318","volume":"99","author":"Liang","year":"2023","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.diabres.2026.113092_b0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.diabres.2026.113092_b0190","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/s41591-024-03483-9","article-title":"Integrating the environmental and genetic architectures of aging and mortality","volume":"31","author":"Argentieri","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2026.113092_b0195","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.037948","article-title":"Cardiovascular health trajectories and prevalent metabolic dysfunction-associated steatotic liver disease in midlife: the CARDIA study","volume":"14","author":"Park","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.diabres.2026.113092_b0200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12916-019-1305-x","article-title":"Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort","volume":"17","author":"Jani","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.diabres.2026.113092_b0205","first-page":"23","article-title":"Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge","volume":"4","author":"Mohamad","year":"2024","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.diabres.2026.113092_b0210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review","volume":"23","author":"Zheng","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2026.113092_b0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.38952","article-title":"Young adult physical activity trajectories and midlife nonalcoholic fatty liver disease","volume":"6","author":"de Brito","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.diabres.2026.113092_b0220","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s40279-023-01918-w","article-title":"Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: a position statement from exercise and sport science Australia","volume":"53","author":"Keating","year":"2023","journal-title":"Sports Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:35:36Z","timestamp":1779111336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"alternative-id":["S0168822726000112"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113092","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden and mortality impact of cardiovascular disease\u2013metabolic dysfunction\u2013associated steatotic liver disease comorbidity","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113092"}}